IDiyas

For the Inventor, By the Inventor

Oxford, OH, United States of America

Thomas L Cupps

USPTO Granted Patents = 23

Average Co-Inventor Count = 3.8

ph-index = 9

Forward Citations = 185(Granted Patents)


Location History:

  • Maineville, OH (US) (1995)
  • Oxford, OH (US) (1991 - 2002)
  • Norwich, NY (US) (2000 - 2002)

Company Filing History:

goldMedal23 out of 17,164 
 
The Procter Gamble Company
 patents

Years Active: 1991-2002

Loading Chart...
23 patents (USPTO):Explore Patents
1. 6486190 - 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability (2002-11-26),
2. 6436978 - Guanidinylamino heterocycle compounds useful as &agr;-2 adrenoceptor agonists (2002-08-20),
3. 6423724 - 7-(2-imidazolinylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists (2002-07-23),
4. 6399598 - Diheterocyclic metalloprotease inhibitors (2002-06-04),
5. 6391878 - Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists (2002-05-21),
6. 6306877 - Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists (2001-10-23),
7. 6225331 - Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists (2001-05-01),
8. 6172095 - Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists (2001-01-09),
9. 6121258 - 1,5-heterocyclic metalloprotease inhibitors (2000-09-18),
10. 612125 - 1,5-heterocyclic metalloprotease inhibitors (2000-09-19),
11. 5916900 - 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 (1999-06-29),
12. 5804587 - 6-(2-imidazolinylamino) quinolines useful as alpha-2 adrenoceptor (1998-09-08),
13. 5739148 - 6-(2-Imidazolinylamino) quinoline compounds useful as alpha-2 (1998-04-14),
14. 5716966 - 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 (1998-02-10),
15. 5691370 - 5-(2-imidazolinylamino)benzimidazole compounds useful as (1997-11-25),

Title: Thomas L Cupps - Innovator in Pharmaceutical Patents

Introduction

Thomas L Cupps, based in Oxford, OH, is a remarkable inventor known for his contributions to pharmaceutical innovations. With a total of 23 patents to his name, he has made significant advancements, particularly in the field of adrenoceptor agonists.

Latest Patents

Among his latest patents are:

1. 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as α-adrenoceptor agonists with improved metabolic stability.

2. Guanidinylamino heterocycle compounds useful as α-2 adrenoceptor agonists.

These inventions highlight his commitment to developing compounds that address critical health issues.

Career Highlights

Thomas currently works at The Procter & Gamble Company, where he continues to push the boundaries of pharmaceutical research and development. His career has been marked by a consistent focus on improving the efficacy and stability of medicinal compounds.

Collaborations

Throughout his career, Thomas has collaborated with notable peers, including Sophie Eva Bogdan and Jeffrey Joseph Ares. These partnerships have facilitated the sharing of ideas and the advancement of innovative healthcare solutions.

Conclusion

Thomas L Cupps stands out as a leading inventor in the pharmaceutical industry, with a robust portfolio of patents that underscores his expertise and dedication to innovation. His work continues to pave the way for new treatments and improvements in patient care, making a lasting impact on the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…